China Ophthalmology Drugs Market Research Report 2017

December 2017 | 95 pages | ID: CF07B360EE6EN
QYResearch

Abstracts

The global Ophthalmology Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Ophthalmology Drugs development status and future trend in China, focuses on top players in China, also splits Ophthalmology Drugs by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Novartis
• Regeneron
• Roche
• Bayer
• Allergan
• Shire
• Mallinckrodt

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• Lucentis (ranibizumab)
• Eylea (aflibercept)
• Avastin (bevacizumab)
• Restasis (cyclosporine)
• Alphagan (brimonidine tartrate)
• Lumigan (bimatoprost)
• Xalatan (latanoprost

On the basis of the end users/application, this report covers

• Chorioretinitis
• Choroiditis
• Retinitis
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Ophthalmology Drugs Market Research Report 2017

1 OPHTHALMOLOGY DRUGS OVERVIEW

1.1 Product Overview and Scope of Ophthalmology Drugs
1.2 Classification of Ophthalmology Drugs by Product Category
  1.2.1 China Ophthalmology Drugs Sales (K Pcs) Comparison by Type (2012-2022)
  1.2.2 China Ophthalmology Drugs Sales (K Pcs) Market Share by Type in 2016
  1.2.3 Lucentis (ranibizumab)
  1.2.4 Eylea (aflibercept)
  1.2.5 Avastin (bevacizumab)
  1.2.6 Restasis (cyclosporine)
  1.2.7 Alphagan (brimonidine tartrate)
  1.2.8 Lumigan (bimatoprost)
  1.2.9 Xalatan (latanoprost
1.3 China Ophthalmology Drugs Market by Application/End Users
  1.3.1 China Ophthalmology Drugs Sales (K Pcs) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Chorioretinitis
  1.3.3 Choroiditis
  1.3.4 Retinitis
  1.3.5 Others
1.4 China Ophthalmology Drugs Market by Region
  1.4.1 China Ophthalmology Drugs Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Ophthalmology Drugs Status and Prospect (2012-2022)
  1.4.3 East China Ophthalmology Drugs Status and Prospect (2012-2022)
  1.4.4 Southwest China Ophthalmology Drugs Status and Prospect (2012-2022)
  1.4.5 Northeast China Ophthalmology Drugs Status and Prospect (2012-2022)
  1.4.6 North China Ophthalmology Drugs Status and Prospect (2012-2022)
  1.4.7 Central China Ophthalmology Drugs Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Ophthalmology Drugs (2012-2022)
  1.5.1 China Ophthalmology Drugs Sales (K Pcs) and Growth Rate (%)(2012-2022)
  1.5.2 China Ophthalmology Drugs Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA OPHTHALMOLOGY DRUGS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Ophthalmology Drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Ophthalmology Drugs Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Ophthalmology Drugs Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)
2.4 China Ophthalmology Drugs Market Competitive Situation and Trends
  2.4.1 China Ophthalmology Drugs Market Concentration Rate
  2.4.2 China Ophthalmology Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Ophthalmology Drugs Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA OPHTHALMOLOGY DRUGS SALES AND REVENUE BY REGION (2012-2017)

3.1 China Ophthalmology Drugs Sales (K Pcs) and Market Share by Region (2012-2017)
3.2 China Ophthalmology Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Ophthalmology Drugs Price (USD/Pcs) by Regions (2012-2017)

4 CHINA '&B1&' SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)'

4.1 China Ophthalmology Drugs Sales (K Pcs) and Market Share by Type/ Product Category (2012-2017)
4.2 China Ophthalmology Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Ophthalmology Drugs Price (USD/Pcs) by Type (2012-2017)
4.4 China Ophthalmology Drugs Sales Growth Rate (%) by Type (2012-2017)

5 CHINA '&B1&' SALES BY APPLICATION (2012-2017)'

5.1 China Ophthalmology Drugs Sales (K Pcs) and Market Share by Application (2012-2017)
5.2 China Ophthalmology Drugs Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA OPHTHALMOLOGY DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ophthalmology Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Regeneron
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Ophthalmology Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Regeneron Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Roche
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Ophthalmology Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Roche Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Bayer
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Ophthalmology Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Bayer Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Allergan
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Ophthalmology Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Allergan Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Shire
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Ophthalmology Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Shire Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Mallinckrodt
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Ophthalmology Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Mallinckrodt Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview

7 OPHTHALMOLOGY DRUGS MANUFACTURING COST ANALYSIS

7.1 Ophthalmology Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ophthalmology Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ophthalmology Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ophthalmology Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA OPHTHALMOLOGY DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.2 China Ophthalmology Drugs Sales (K Pcs) Forecast by Type (2017-2022)
11.3 China Ophthalmology Drugs Sales (K Pcs) Forecast by Application (2017-2022)
11.4 China Ophthalmology Drugs Sales (K Pcs) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Ophthalmology Drugs Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Ophthalmology Drugs Sales (K Pcs) by Application (2016-2022)
Figure Product Picture of Ophthalmology Drugs
Table China Ophthalmology Drugs Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Ophthalmology Drugs Sales Volume Market Share by Types in 2016
Figure Lucentis (ranibizumab) Product Picture
Figure Eylea (aflibercept) Product Picture
Figure Avastin (bevacizumab) Product Picture
Figure Restasis (cyclosporine) Product Picture
Figure Alphagan (brimonidine tartrate) Product Picture
Figure Lumigan (bimatoprost) Product Picture
Figure Xalatan (latanoprost Product Picture
Figure China Ophthalmology Drugs Sales (K Pcs) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Ophthalmology Drugs by Application in 2016
Figure Chorioretinitis Examples
Table Key Downstream Customer in Chorioretinitis
Figure Choroiditis Examples
Table Key Downstream Customer in Choroiditis
Figure Retinitis Examples
Table Key Downstream Customer in Retinitis
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Ophthalmology Drugs Sales (K Pcs) and Growth Rate (%)(2012-2022)
Figure China Ophthalmology Drugs Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Ophthalmology Drugs Sales of Key Players/Manufacturers (2012-2017)
Table China Ophthalmology Drugs Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Ophthalmology Drugs Sales Share (%) by Players/Manufacturers
Figure 2017 China Ophthalmology Drugs Sales Share (%) by Players/Manufacturers
Table China Ophthalmology Drugs Revenue by Players/Manufacturers (2012-2017)
Table China Ophthalmology Drugs Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Ophthalmology Drugs Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Ophthalmology Drugs Revenue Market Share (%) by Players/Manufacturers
Table China Market Ophthalmology Drugs Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Ophthalmology Drugs Average Price of Key Players/Manufacturers in 2016
Figure China Ophthalmology Drugs Market Share of Top 3 Players/Manufacturers
Figure China Ophthalmology Drugs Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Ophthalmology Drugs Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Ophthalmology Drugs Product Category
Table China Ophthalmology Drugs Sales (K Pcs) by Regions (2012-2017)
Table China Ophthalmology Drugs Sales Share (%) by Regions (2012-2017)
Figure China Ophthalmology Drugs Sales Share (%) by Regions (2012-2017)
Figure China Ophthalmology Drugs Sales Market Share (%) by Regions in 2016
Table China Ophthalmology Drugs Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Ophthalmology Drugs Revenue Market Share (%) by Regions (2012-2017)
Figure China Ophthalmology Drugs Revenue Market Share (%) by Regions (2012-2017)
Figure China Ophthalmology Drugs Revenue Market Share (%) by Regions in 2016
Table China Ophthalmology Drugs Price (USD/Pcs) by Regions (2012-2017)
Table China Ophthalmology Drugs Sales (K Pcs) by Type (2012-2017)
Table China Ophthalmology Drugs Sales Share (%) by Type (2012-2017)
Figure China Ophthalmology Drugs Sales Share (%) by Type (2012-2017)
Figure China Ophthalmology Drugs Sales Market Share (%) by Type in 2016
Table China Ophthalmology Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Ophthalmology Drugs Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Ophthalmology Drugs by Type (2012-2017)
Figure Revenue Market Share of Ophthalmology Drugs by Type in 2016
Table China Ophthalmology Drugs Price (USD/Pcs) by Types (2012-2017)
Figure China Ophthalmology Drugs Sales Growth Rate (%) by Type (2012-2017)
Table China Ophthalmology Drugs Sales (K Pcs) by Applications (2012-2017)
Table China Ophthalmology Drugs Sales Market Share (%) by Applications (2012-2017)
Figure China Ophthalmology Drugs Sales Market Share (%) by Application (2012-2017)
Figure China Ophthalmology Drugs Sales Market Share (%) by Application in 2016
Table China Ophthalmology Drugs Sales Growth Rate (%) by Application (2012-2017)
Figure China Ophthalmology Drugs Sales Growth Rate (%) by Application (2012-2017)
Table Novartis Ophthalmology Drugs Basic Information List
Table Novartis Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Novartis Ophthalmology Drugs Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Novartis Ophthalmology Drugs Sales Market Share (%) in China (2012-2017)
Figure Novartis Ophthalmology Drugs Revenue Market Share (%) in China (2012-2017)
Table Regeneron Ophthalmology Drugs Basic Information List
Table Regeneron Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Regeneron Ophthalmology Drugs Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Regeneron Ophthalmology Drugs Sales Market Share (%) in China (2012-2017)
Figure Regeneron Ophthalmology Drugs Revenue Market Share (%) in China (2012-2017)
Table Roche Ophthalmology Drugs Basic Information List
Table Roche Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Roche Ophthalmology Drugs Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Roche Ophthalmology Drugs Sales Market Share (%) in China (2012-2017)
Figure Roche Ophthalmology Drugs Revenue Market Share (%) in China (2012-2017)
Table Bayer Ophthalmology Drugs Basic Information List
Table Bayer Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Bayer Ophthalmology Drugs Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Bayer Ophthalmology Drugs Sales Market Share (%) in China (2012-2017)
Figure Bayer Ophthalmology Drugs Revenue Market Share (%) in China (2012-2017)
Table Allergan Ophthalmology Drugs Basic Information List
Table Allergan Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Allergan Ophthalmology Drugs Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Allergan Ophthalmology Drugs Sales Market Share (%) in China (2012-2017)
Figure Allergan Ophthalmology Drugs Revenue Market Share (%) in China (2012-2017)
Table Shire Ophthalmology Drugs Basic Information List
Table Shire Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Shire Ophthalmology Drugs Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Shire Ophthalmology Drugs Sales Market Share (%) in China (2012-2017)
Figure Shire Ophthalmology Drugs Revenue Market Share (%) in China (2012-2017)
Table Mallinckrodt Ophthalmology Drugs Basic Information List
Table Mallinckrodt Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Mallinckrodt Ophthalmology Drugs Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Mallinckrodt Ophthalmology Drugs Sales Market Share (%) in China (2012-2017)
Figure Mallinckrodt Ophthalmology Drugs Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ophthalmology Drugs
Figure Manufacturing Process Analysis of Ophthalmology Drugs
Figure Ophthalmology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Ophthalmology Drugs Major Players/Manufacturers in 2016
Table Major Buyers of Ophthalmology Drugs
Table Distributors/Traders List
Figure China Ophthalmology Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure China Ophthalmology Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Ophthalmology Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table China Ophthalmology Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Ophthalmology Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Ophthalmology Drugs Sales Volume Market Share Forecast by Type in 2022
Table China Ophthalmology Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure China Ophthalmology Drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Ophthalmology Drugs Sales Volume Market Share Forecast by Application in 2022
Table China Ophthalmology Drugs Sales (K Pcs) Forecast by Regions (2017-2022)
Table China Ophthalmology Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure China Ophthalmology Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure China Ophthalmology Drugs Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources